Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Herman

Showing results (51-60 of 375) with videos related to

Pageof 38
Sort By:
The Journal of the American Academy of Orthopaedic Surgeons|March 3, 2017
AAOS Appropriate Use Criteria: Anterior Cruciate Ligament Injury Prevention ProgramsKevin R Vincent, Daniel C Herman
American Journal of Ophthalmology|February 15, 1987
Anterior subcapsular cataracts as a possible adverse ocular reaction to isotretinoinD C Herman, J A Dyer
Analytical Biochemistry|April 1, 1975
Microanalytical and preparative peptide separations with a modified technicon autoanalyzerA C Herman, T C Vanaman
The American Psychologist|October 9, 2002
A research agenda for school violence preventionWendy M Reinke, Keith C Herman
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 14, 2005
Factor VIII inhibitor associated with peginterferonC Herman, L Boggio, D Green
Current Sports Medicine Reports|May 9, 2018
Saphenous Nerve Block for the Assessment of Knee Pain Refractory to Conservative TreatmentDaniel C Herman, Kevin R Vincent
Analytical Chemistry|September 15, 1996
Affinity chromatography with immunochemical detection applied to the analysis of human methionyl granulocyte colony stimulating factor in serumK J Miller, A C Herman
The American Journal of Sports Medicine|July 31, 2016
Drop-Jump Landing Varies With Baseline Neurocognition: Implications for Anterior Cruciate Ligament Injury Risk and PreventionDaniel C Herman, Jeffrey T Barth
American Journal of Ophthalmology|January 15, 1987
Corneal opacities secondary to topical naphazoline and antazoline (Albalon-A)D C Herman, G B Bartley
American Family Physician|August 1, 1976
RelactationL R Waletzky, E C Herman
Pageof 38

Showing results (51-60 of 375) with videos related to

Sort By:
Pageof 38
The Journal of the American Academy of Orthopaedic Surgeons|March 3, 2017
AAOS Appropriate Use Criteria: Anterior Cruciate Ligament Injury Prevention ProgramsKevin R Vincent, Daniel C Herman
American Journal of Ophthalmology|February 15, 1987
Anterior subcapsular cataracts as a possible adverse ocular reaction to isotretinoinD C Herman, J A Dyer
Analytical Biochemistry|April 1, 1975
Microanalytical and preparative peptide separations with a modified technicon autoanalyzerA C Herman, T C Vanaman
The American Psychologist|October 9, 2002
A research agenda for school violence preventionWendy M Reinke, Keith C Herman
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 14, 2005
Factor VIII inhibitor associated with peginterferonC Herman, L Boggio, D Green
Current Sports Medicine Reports|May 9, 2018
Saphenous Nerve Block for the Assessment of Knee Pain Refractory to Conservative TreatmentDaniel C Herman, Kevin R Vincent
Analytical Chemistry|September 15, 1996
Affinity chromatography with immunochemical detection applied to the analysis of human methionyl granulocyte colony stimulating factor in serumK J Miller, A C Herman
The American Journal of Sports Medicine|July 31, 2016
Drop-Jump Landing Varies With Baseline Neurocognition: Implications for Anterior Cruciate Ligament Injury Risk and PreventionDaniel C Herman, Jeffrey T Barth
American Journal of Ophthalmology|January 15, 1987
Corneal opacities secondary to topical naphazoline and antazoline (Albalon-A)D C Herman, G B Bartley
American Family Physician|August 1, 1976
RelactationL R Waletzky, E C Herman
Pageof 38